Health In Tech Inc (NASDAQ:HIT) price on Thursday, March 20, fall -3.15% below its previous day’s close as a downside momentum from buyers pushed the stock’s value to $0.70.
A look at the stock’s price movement, the close in the last trading session was $0.72, moving within a range at $0.65 and $0.7199. The PE ratio in trailing twelve months stood at 56.46. Turning to its 52-week performance, $7.59 and $0.67 were the 52-week high and 52-week low respectively. Overall, HIT moved -89.44% over the past month.
Health In Tech Inc’s market cap currently stands at around $8.19 million, with investors looking forward to this quarter’s earnings report slated for in April.
HIT’s current price about -85.67% and -86.95% off the 20-day and 50-day simple moving averages respectively. The Relative Strength Index (RSI, 14) currently prints 18.55, while 7-day volatility ratio is 28.54% and 42.66% in the 30-day chart. Further, Health In Tech Inc (HIT) has a beta value of 0, and an average true range (ATR) of 0.65.
If we refocus on Health In Tech Inc (NASDAQ:HIT), historical trading data shows that trading volumes averaged 4.76 over the past 10 days and 1.90 million over the past 3 months. The company’s latest data on shares outstanding shows there are 42.91 million shares.
The 85.54% of Health In Tech Inc’s shares are in the hands of company insiders while institutional holders own 0.01% of the company’s shares. Also important is the data on short interest which shows that short shares stood at 0.12 million on 2025-02-28, giving us a short ratio of 0.07. The data shows that as of 2025-02-28 short interest in Health In Tech Inc (HIT) stood at 97.0 of shares outstanding, with shares short rising to 17143.0 registered in 2025-01-31. Current price change has pushed the stock -86.93% YTD, which shows the potential for further growth is there. It is this reason that could see investor optimism for the HIT stock continues to rise going into the next quarter.
